drugset / Trial / NCT00189878

A Study of the Use of Methotrexate in the Treatment of Chronic Idiopathic Urticaria

NCT00189878 ↗

Phase 2 Terminated 3 enrolled Barnsley Hospital
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether methotrexate produces significant improvement in chronic idiopathic urticaria, compared with placebo

Timeline

Start
2003-08
Primary completion
2008-08
Completion
2008-08

Outcome

Outcome not reported

Stopped (Enrollment): “unable to recruit”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methotrexate Small molecule 10 mg —
Comparator Methotrexate Small molecule 15 mg —